SYROS PHARMACEUTICALS INC (SYRS) Earnings History & Surprises

NASDAQ:SYRS • US87184Q2066

Current stock price

0.1172 USD
-0.01 (-8.44%)
At close:
0.1072 USD
-0.01 (-8.53%)
After Hours:

SYRS Earnings overview

Past quarterly earnings results for SYROS PHARMACEUTICALS INC (SYRS), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 12, 2025
Period
Q4 / 2024
EPS Estimate
-$0.66
Revenue Estimate

Last Reported

Most Recent
Release Date
Mar 25, 2025
Period
Q3 / 2024
EPS Reported
-$0.16
EPS Surprise
78.21%
Revenue Surprise
-100.00%

Beat Rate

Last 8 Quarters
31%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2024 -0.16 -0.73 78.21% 88.81% 459K -100.00% -100.00%
Q2 2024 -0.59 -0.78 24.66% 54.62% 469.2K -100.00% -100.00%
Q1 2024 -0.10 -0.89 88.72% 88.24% 734.4K -100.00% -100.00%
Q4 2023 -2.18 -1.17 -86.73% -1,182.35% 387K 2.04M -81.03% 151.60%
Q3 2023 -1.43 -1.16 -22.83% 55.45% 3.762M 4.019M -6.39% -3.29%
Q2 2023 -1.30 -1.15 -12.95% 75.93% 2.833M 3.57M -20.64% -54.89%
Q1 2023 -0.85 -1.11 23.58% 78.75% 2.954M 3.325M -11.16% -46.00%
Q4 2022 -0.17 -1.38 87.67% 95.53% -750K 4.06M -118.47% -109.62%
Q3 2022 -3.21 -4.09 21.52% 21.71% 3.89M 5.284M -26.38% -31.75%
Q2 2022 -5.40 -4.16 -29.76% -50.00% 6.28M 4.769M 31.68% 21.71%
Q1 2022 -4.00 -4.79 16.56% -73.91% 5.47M 5.022M 8.92% 13.25%
Q4 2021 -3.80 -4.75 20.00% 38.71% 7.8M 4.896M 59.31% 36.84%
Q3 2021 -4.10 -4.49 8.65% 4.65% 5.7M 4.579M 24.48% 48.83%
Q2 2021 -3.60 -3.80 5.22% 5.26% 5.16M 4.217M 22.36% 61.76%
Q1 2021 -2.30 -4.74 51.48% 41.03% 4.83M 2.723M 77.38% 102.94%
Q4 2020 -6.20 -5.09 -21.75% - 5.7M 2.75M 107.27% -
Q3 2020 -4.30 -3.92 -9.67% - 3.83M 2.595M 47.59% -
Q2 2020 -3.80 -4.10 7.33% - 3.19M 1.94M 64.43% -
Q1 2020 -3.90 -4.42 11.85% - 2.38M 1.655M 43.81% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

SYRS EPS Q2Q GrowthSYRS EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 0 -200 -400 -600 -800 -1K

Revenue Historical Q2Q growth and Acceleration

SYRS Revenue Q2Q GrowthSYRS Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 0 50 -50 100 -100 150

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
26.22%
Max EPS beat (4)
88.72%
Min EPS beat (4)
-86.73%

Revenue beat statistics

Revenue beat (4)
0
Average Revenue beat (4)
-95.26%
Max Revenue beat (4)
-81.03%
Min Revenue beat (4)
-100.00%

Analysis

In the last 4 quarters, SYRS has beaten EPS estimates in 3 out of 4 releases
SYRS has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, SYRS has beaten the EPS estimates by 26.2% on average.
In the last 4 quarters, SYRS reported -95.3% below the revenue estimates on average.
SYRS Overview SYRS Technical Analysis Report SYRS Fundamental Analysis Report SYRS Forecast & Price Target
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

SYROS PHARMACEUTICALS INC / SYRS Earnings FAQ

When did SYROS PHARMACEUTICALS INC (SYRS) report earnings last quarter?

SYROS PHARMACEUTICALS INC (SYRS) last reported earnings on 3/25/2025.

Did SYROS PHARMACEUTICALS INC (SYRS) beat earnings estimates last quarter?

SYROS PHARMACEUTICALS INC (SYRS) beat EPS estimates and missed revenue estimates in the most recent quarter.

What percentage of the time does SYRS stock beat earnings estimates?

In the last 4 quarters, SYROS PHARMACEUTICALS INC (SYRS) has beaten EPS estimates in 3 out of 4 releases.